Naltrexone in Obsessive-Compulsive Disorder: an Open- Label Trial
| Author | Aram Hamidi | en |
| Author | Bijan Jahanguiri | en |
| Author | Mehdi Nasr Nasr Esfahanini | en |
| Author | Mahbuobeh Dadfar | en |
| Issued Date | 2007-01-30 | en |
| Abstract | Objective: In spite of introduction of novel drugs, Obsessive-Compulsive Disorder (OCD) has still found no suitable treatment. On the other hand, high rates of co-morbidity of OCD with bipolar spectrum disorders are increasingly recognized. Mood switching and development of rapid cycling with antidepressants are significant problems in these patients. From this viewpoint, introducing a non-antidepressant anti-OCD drug has great theoretical and clinical importance. In this open-label clinical trial we evaluated the effects of naltrexone on OCD symptoms | en |
| DOI | https://doi.org/ | en |
| URI | https://brieflands.com/journals/ijpbs/articles/2701 | en |
| Keyword | Bipolar Disorder | en |
| Keyword | Naltrexone | en |
| Keyword | Obsessive-Compulsive Disorder | en |
| Publisher | Brieflands | en |
| Title | Naltrexone in Obsessive-Compulsive Disorder: an Open- Label Trial | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpbs-v1n1p16-en.pdf
- Size:
- 94.55 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF